Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Inhibitory Mechanism of an Allosteric Antibody Targeting the Glucagon Receptor

Journal Article · · Journal of Biological Chemistry
 [1];  [2];  [3];  [3];  [4];  [5];  [5];  [2];  [6];  [7]; ;  [2];  [7];  [3]
  1. Genentech, Inc., South San Francisco, CA (United States). Dept. of Structural Biology; DOE/OSTI
  2. Genentech, Inc., South San Francisco, CA (United States). Dept. of Antibody Engineering
  3. Genentech, Inc., South San Francisco, CA (United States). Dept. of Molecular Biology
  4. Genentech, Inc., South San Francisco, CA (United States). Dept. of Early Discovery Biochemistry
  5. Genentech, Inc., South San Francisco, CA (United States). Dept. of Biomedical Imaging
  6. Genentech, Inc., South San Francisco, CA (United States). Dept. of Protein Chemistry
  7. Genentech, Inc., South San Francisco, CA (United States). Dept. of Structural Biology

Elevated glucagon levels and increased hepatic glucagon receptor (GCGR) signaling contribute to hyperglycemia in type 2 diabetes. We have identified a monoclonal antibody that inhibits GCGR, a class B G-protein coupled receptor (GPCR), through a unique allosteric mechanism. Receptor inhibition is mediated by the binding of this antibody to two distinct sites that lie outside of the glucagon binding cleft. One site consists of a patch of residues that are surface-exposed on the face of the extracellular domain (ECD) opposite the ligand-binding cleft, whereas the second binding site consists of residues in the A helix of the ECD. A docking model suggests that the antibody does not occlude the ligand-binding cleft. We solved the crystal structure of GCGR ECD containing a naturally occurring G40S mutation and found a shift in the register of the A helix that prevents antibody binding. We also found that alterations in the A helix impact the normal function of GCGR. We present a model for the allosteric inhibition of GCGR by a monoclonal antibody that may form the basis for the development of allosteric modulators for the treatment of diabetes and other class B GPCR-related diseases.

Research Organization:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Biological and Environmental Research (BER). Biological Systems Science Division
Grant/Contract Number:
AC02-05CH11231
OSTI ID:
1625083
Journal Information:
Journal of Biological Chemistry, Journal Name: Journal of Biological Chemistry Journal Issue: 50 Vol. 288; ISSN 0021-9258
Publisher:
American Society for Biochemistry and Molecular BiologyCopyright Statement
Country of Publication:
United States
Language:
English

References (46)

Effects of a novel glucagon receptor antagonist (Bay 27-9955) on glucagon-stimulated glucose production in humans journal November 2001
Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists journal October 2004
Bivalent antibody phage display mimics natural immunoglobulin journal January 2004
High-affinity Human Antibodies from Phage-displayed Synthetic Fab Libraries with a Single Framework Scaffold journal July 2004
A hydrophobic site on the GLP-1 receptor extracellular domain orients the peptide ligand for signal transduction journal April 2013
RAMP-ing up Class-B GPCR ECD Structural Coverage journal September 2010
Passing the baton in class B GPCRs: peptide hormone activation via helix induction? journal June 2009
Comprehensive Functional Maps of the Antigen-binding Site of an Anti-ErbB2 Antibody Obtained with Shotgun Scanning Mutagenesis journal July 2002
A missense mutation in the glucagon receptor gene is associated with non–insulin–dependent diabetes mellitus journal March 1995
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders journal January 2009
Heterodimers and family-B GPCRs: RAMPs, CGRP and adrenomedullin journal October 2004
Molecular basis for negative regulation of the glucagon receptor journal August 2012
Characterization of a Novel, Non-peptidyl Antagonist of the Human Glucagon Receptor journal March 1999
Structural and Pharmacological Characterization of Novel Potent and Selective Monoclonal Antibody Antagonists of Glucose-dependent Insulinotropic Polypeptide Receptor journal May 2013
Molecular Recognition of Corticotropin-releasing Factor by Its G-protein-coupled Receptor CRFR1 journal November 2008
Coot model-building tools for molecular graphics journal November 2004
Long-Term Inhibition of the Glucagon Receptor with a Monoclonal Antibody in Mice Causes Sustained Improvement in Glycemic Control, with Reversible α-Cell Hyperplasia and Hyperglucagonemia journal August 2009
Small Molecule Allosteric Modulation of the Glucagon-Like Peptide-1 Receptor Enhances the Insulinotropic Effect of Oxyntomodulin journal August 2012
LRP6 Mediates cAMP Generation by G Protein-Coupled Receptors Through Regulating the Membrane Targeting of G s journal March 2011
Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover journal January 2012
PHENIX: a comprehensive Python-based system for macromolecular structure solution. text January 2010
Allosteric Modulators of Class B G-Protein-Coupled Receptors journal September 2007
The Gly40Ser Mutation in the Human Glucagon Receptor Gene Associated With NIDDM Results in a Receptor With Reduced Sensitivity to Glucagon journal June 1996
HADDOCK versus HADDOCK: New features and performance of HADDOCK2.0 on the CAPRI targets journal September 2007
Altered renal sodium handling and hypertension in men carrying the glucagon receptor gene (Gly40Ser) variant journal July 2001
Physiological and genetic characterization of the Gly40Ser mutation in the glucagon receptor gene in the Sardinian population journal January 1997
Comprehensive Functional Maps of the Antigen-binding Site of an Anti-ErbB2 Antibody Obtained with Shotgun Scanning Mutagenesis journal July 2002
[21] Phage display for selection of novel binding peptides book January 2000
Crystal Structure of the Ectodomain Complex of the CGRP Receptor, a Class-B GPCR, Reveals the Site of Drug Antagonism journal September 2010
Allostery in GPCRs: ‘MWC’ revisited journal December 2011
GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation journal February 2008
Heterodimers and family-B GPCRs: RAMPs, CGRP and adrenomedullin journal October 2004
NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor journal August 2004
Molecular recognition of parathyroid hormone by its G protein-coupled receptor journal March 2008
Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor* journal January 2010
Structural and Pharmacological Characterization of Novel Potent and Selective Monoclonal Antibody Antagonists of Glucose-dependent Insulinotropic Polypeptide Receptor journal May 2013
Origins of PDZ Domain Ligand Specificity: STRUCTURE DETERMINATION AND MUTAGENESIS OF THE ERBIN PDZ DOMAIN journal November 2002
Molecular Recognition of Corticotropin-releasing Factor by Its G-protein-coupled Receptor CRFR1 journal November 2008
Mutation of the glucagon receptor gene and diabetes mellitus in the UK: association or founder effect? journal January 1995
Coot model-building tools for molecular graphics journal November 2004
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs?: CTR/CLR and family B GPCRs? journal April 2012
Fully Human Monoclonal Antibodies Antagonizing the Glucagon Receptor Improve Glucose Homeostasis in Mice and Monkeys journal January 2009
Amelioration of Type 2 Diabetes by Antibody-Mediated Activation of Fibroblast Growth Factor Receptor 1 journal December 2011
Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover journal January 2012
Modulation of β-Catenin Signaling by Glucagon Receptor Activation journal March 2012

Cited By (14)

Glucagon Couples Hepatic Amino Acid Catabolism to mTOR-Dependent Regulation of α-Cell Mass journal July 2015
Paralog-divergent Features May Help Reduce Off-target Effects of Drugs: Hints from Glucagon Subfamily Analysis journal August 2017
Molecular mechanism of an antagonistic antibody against glucose-dependent insulinotropic polypeptide receptor journal January 2020
Case study: Paralog diverged features may help reduce off-target effects of drugs journal September 2016
Camelid antibodies, more than meets the eye dissertation January 2020
Transmembrane signal transduction by peptide hormones via family B G protein-coupled receptors journal November 2015
Effect of hydrophobic and hydrogen bonding interactions on the potency of ß‐alanine analogs of G‐protein coupled glucagon receptor inhibitors journal September 2019
Allosteric Modulation as a Unifying Mechanism for Receptor Function and Regulation journal August 2016
Phase-plate cryo-EM structure of a class B GPCR–G-protein complex journal April 2017
Mechanisms of signalling and biased agonism in G protein-coupled receptors journal August 2018
DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loops journal May 2016
Allosteric modulation as a unifying mechanism for receptor function and regulation journal September 2017
Hepatic Gi signaling regulates whole-body glucose homeostasis journal January 2018
Inhibition and Reversal of Microbial Attachment by an Antibody with Parasteric Activity against the FimH Adhesin of Uropathogenic E. coli journal May 2015

Similar Records

Molecular Recognition of Corticotropin releasing Factor by Its G protein-coupled Receptor CRFR1
Journal Article · Wed Jan 14 23:00:00 EST 2009 · J. Biol. Chem. · OSTI ID:1006952

Molecular basis for activation of G protein-coupled receptor kinases
Journal Article · Fri Mar 16 00:00:00 EDT 2012 · EMBO J. · OSTI ID:1034566

Crystal Structure of the PAC1R Extracellular Domain Unifies a Consensus Fold for Hormone Recognition by Class B G-Protein Coupled Receptors
Journal Article · Mon Feb 20 23:00:00 EST 2012 · PLoS One · OSTI ID:1031929